Suppr超能文献

颗粒工程:小分子药物开发过程中建立药物物质物理性质规范的策略。

Particle engineering: a strategy for establishing drug substance physical property specifications during small molecule development.

机构信息

Product Research and Development Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

出版信息

J Pharm Sci. 2010 Jan;99(1):51-75. doi: 10.1002/jps.21801.

Abstract

A strategy for physical property control of a drug substance has been developed that utilizes a science-based approach to define key drivers for particle control. These drivers are based on in vivo performance (or expected performance), content uniformity of the drug substance in drug product, and manufacturability of drug product. Quality by design principles have been used in developing the strategy. The strategy has been designed to provide expectations in terms of particle control at each state of development, translating to early-phase projects and carrying through until launch and beyond.

摘要

已经制定了一种药物物质物理性质控制的策略,该策略利用基于科学的方法来定义控制颗粒的关键因素。这些因素基于体内性能(或预期性能)、药物产品中药物物质的含量均匀性和药物产品的可制造性。在制定该策略时使用了质量源于设计的原则。该策略旨在为每个开发阶段的颗粒控制提供预期,从而转化为早期项目,并持续到推出和以后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验